EQT: Distribute Rating After Q3 FY12/26 Earnings

EQT is rated Distribute at $56.29, closing an Accumulate call that returned 56% before dividends. In Q3 FY12/26, revenue fell 9.6% year over year and volumes declined 8%, while adjusted EPS of $0.42 beat consensus and capex was 10% below guidance. The Distribute rating reflects a cycle call: the current 44% trailing free cash flow margin has historically preceded weaker stock performance.

Analysis

EQT’s elevated free-cash-flow margin is a potential mean-reversion signal, not a standalone sell trigger: it may reflect favorable gas realizations and disciplined spending, while lower volumes create a separate question about production durability. The asymmetry is that the stock can lose support if margins compress before volumes recover, but a short can be squeezed if gas prices, weather, or LNG demand tighten the market. Lower spending could also constrain future Appalachian supply, supporting prices for producers broadly; it does not automatically confer a relative advantage on EQT if its own output continues to decline.

For the next few weeks, the prior run-up argues for taking some gains rather than adding. Over 1–3 months, track EQT’s production guidance, realized prices/basis, and whether capex underspending is timing or a sustainable reduction. Over 6–18 months, the key test is whether margin normalization coincides with resilient volumes and balance-sheet discipline. The historical margin/stock relationship cited in the source is not independently established here and should not be treated as a timing rule. A sustained production recovery with stable gas pricing would weaken the distribute thesis; falling volumes alongside lower realized prices would strengthen it.

Key Decisions for Investors

• Trim an overweight EQT position into strength rather than initiate an outright short on this signal alone; the source provides no valuation or forward-guidance evidence to support a price target.
• Set a 1–3 month watch on production guidance, realized gas prices and Appalachian basis, and capex versus plan. Treat continued volume weakness plus margin compression as confirmation to reduce further.
• Avoid treating EQT’s spending restraint as an unambiguous positive: verify whether it reflects timing or reduced sustaining investment before underwriting future output.
• Falsification: reconsider the cautious stance if EQT reports a sustained volume recovery and cash margins remain resilient; reassess more negatively if volumes fall further while realized pricing weakens.